Ivermectin: all 162 studies that test it
Page 1 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksEnrolling by invitationNCT07888595Early Phase 1
- Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in UgandaNot yet recruitingNCT07873398Phase 3
- Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsRecruitingNCT07707817Not applicable
- Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of TrachomaNot yet recruitingNCT07657143Phase 4
- Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)Not yet recruitingNCT07487805Phase 2
- the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.Not yet recruitingNCT07396714Early Phase 1
- Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of ScabiesNot yet recruitingNCT06896929Phase 2
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingNCT05946642Phase 3
- Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast CancerRecruitingNCT05318469Phase 1/2
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingNCT05041907Phase 2
- The Efficacy of Ivermectin in Larger Doses in COVID-19 TreatmentRecruitingNCT04351347Phase 2/3
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
- Efficacy, Safety and Acceptability of Ivermectin ODT in PSACCompletedNCT06184399Phase 2Results posted
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)CompletedNCT05894538Phase 3Results posted
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)CompletedNCT05736861Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 PreventionCompletedNCT05305560Phase 2Results posted
- Loiasis Cross-reactive Antigenemia and Treatment-related Adverse EventsCompletedNCT05085665Phase 4Results posted
- ACTIV-6: COVID-19 Study of Repurposed MedicationsCompletedNCT04885530Phase 3Results posted
- Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides StercoralisCompletedNCT04848688Phase 3Results posted
- Efficacy and Safety of MOX/ALB Co-administrationCompletedNCT04726969Phase 3Results posted
- Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administrationCompletedNCT04700423Phase 2/3Results posted
- Ivermectin for Severe COVID-19 ManagementCompletedNCT04646109Phase 3Results posted
- Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19CompletedNCT04632706Phase 1Results posted
- Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 InfectionCompletedNCT04523831Phase 3Results posted
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)CompletedNCT04510194Phase 3Results posted
- Prophylactic Ivermectin in COVID-19 ContactsCompletedNCT04422561Phase 2/3Results posted
- Moxidectin for LF, Cote d'Ivoire (DOLF)CompletedNCT04410406Phase 3Results posted
- Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without SymptomsCompletedNCT04407507Phase 2Results posted
- Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal TrialCompletedNCT04390022Phase 2Results posted
- Novel Agents for Treatment of High-risk COVID-19 Positive PatientsTerminatedNCT04374019Phase 2Results posted
- Effectiveness of Ivermectin as add-on Therapy in COVID-19 ManagementCompletedNCT04343092Phase 1Results posted
- Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric PatientsCompletedNCT04041453Phase 2Results posted
- Repeat Ivermectin Mass Drug Administrations for MALaria Control IICompletedNCT03967054Phase 3Results posted
- Treatment of Strongyloides InfectionTerminatedNCT03605758Phase 3Results posted
- Efficacy and Safety of IVM/ALB Co-administrationCompletedNCT03527732Phase 2/3Results posted
- Ivermectin and Human ImmunityCompletedNCT03459794Early Phase 1Results posted
- A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head LiceCompletedNCT03337490Phase 3Results posted
- Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic DermatitisCompletedNCT03250624Phase 2Results posted
- Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon IslandsCompletedNCT03236168Phase 3Results posted
- Efficacy and Safety of CD5024 1% in Acne VulgarisCompletedNCT03034460Phase 2Results posted
- Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.CompletedNCT02806414Phase 1/2Results posted
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT02795117Phase 3Results posted
- Azithromycin - Ivermectin Mass Drug Administration for Skin DiseaseCompletedNCT02775617Phase 4Results posted
- MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.CompletedNCT02616250Phase 4Results posted
- Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy StudyCompletedNCT02509481Phase 2/3Results posted
- Development of Ivermectin for Alcohol Use DisordersCompletedNCT02046200Phase 1/2Results posted
- Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in LoiasisCompletedNCT01593722Phase 4Results posted
- Phase 3 Papulopustular Rosacea StudyCompletedNCT01494467Phase 3Results posted
- CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) StudyCompletedNCT01493947Phase 3Results posted
- Phase 3 Papulopustular Rosacea StudyCompletedNCT01493687Phase 3Results posted
- Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in MalawiTerminatedNCT01213576Not applicableResults posted
- A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested SubjectsCompletedNCT01068158Phase 3Results posted
- A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice InfestationCompletedNCT01066585Phase 3Results posted
- Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested SubjectsCompletedNCT00994422Phase 2Results posted
- A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of AgeCompletedNCT00988533Phase 1Results posted
- A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.CompletedNCT07795567Phase 1
- Efficacy of Ivermectin in the Treatment of Plane WartsCompletedNCT07710638Phase 2
- Ivermectin Repurposed for the Treatment of PKDLCompletedNCT07286604Early Phase 1
- Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g CreamCompletedNCT06557603Phase 1
- Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, ThailandActive, not recruitingNCT06332872Phase 4
- Oral Ivermectin for Chikungunya Viral InfectionCompletedNCT06259383Phase 3
- Repurposing Ivermectin for PKDL TreatmentCompletedNCT06251739Early Phase 1
- Safety and Efficacy of Novel Combination Regimens for Treatment of OnchocerciasisActive, not recruitingNCT06070116Phase 2
- Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial RosaceaCompletedNCT06033352Phase 2
- Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50TerminatedNCT05993143Phase 3
- Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical TrialCompletedNCT05930002Not applicable
- Ivermectin/ Permethrin for ScabiesCompletedNCT05819983Phase 4
- Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis CapitisCompletedNCT05643820Phase 1
- Ivermectin-artemisinin Combination Therapy for Eradication of MalariaStatus unknownNCT05605925Phase 4
- Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)Active, not recruitingNCT05500326Phase 2
- Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of ScabiesCompletedNCT05362513Phase 1
- Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New GuineaWithdrawnNCT05283954Phase 2/3
- Ivermectin for Post Exposure Prophylaxis of Covid-19TerminatedNCT05231603Phase 3
- Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%CompletedNCT05213585Phase 3
- Ivermectin With Favipiravir in Mild-to-moderate COVID-19 PatientsStatus unknownNCT05155527Phase 2
- Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting ConditionsCompletedNCT05082753Phase 1
- Efficacy of Ivermectin in COVID-19CompletedNCT05076253Phase 1/2
- Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]Status unknownNCT05060666Phase 3
- Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19Status unknownNCT05040724Phase 3
- Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)CompletedNCT04966702Phase 3
- MANS-NRIZ Trial for COVID-19 Treatment : Extension StudyStatus unknownNCT04959786Phase 2/3
- Remdesivir- Ivermectin Combination Therapy in Severe Covid-19Status unknownNCT04944082Phase 4
- Ivermectin Versus Standard Treatment in Mild COVID-19Status unknownNCT04937569Phase 3
- Ivermectin Treatment Efficacy in Covid-19 High Risk PatientsCompletedNCT04920942Phase 3
- Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)CompletedNCT04894721Phase 2/3
- The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19WithdrawnNCT04891250Phase 4
- Ivermectina Colombia (IVERCOL)Status unknownNCT04886362Phase 2/3
- Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)CompletedNCT04854460Phase 1
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 3
- Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)Status unknownNCT04836299Phase 2
- Efficacy of Ivermectin in Outpatients With Non-severe COVID-19Status unknownNCT04834115Phase 3
- Ivermectin Reproposing for Mild Stage COVID-19 OutpatientsCompletedNCT04784481Phase 1/2
- Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.Status unknownNCT04779047Phase 4
- Ivermectin Role in Covid-19 Clinical TrialCompletedNCT04746365Phase 4
- Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 PatientsCompletedNCT04739410Phase 4
- An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related HospitalizationStatus unknownNCT04729140Phase 4
- Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19Status unknownNCT04716569Phase 2/3
- The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)Status unknownNCT04712279Phase 2/3
- Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the GambiaStatus unknownNCT04703608Phase 3
- Study in COvid-19 Patients With iveRmectin (CORVETTE-01)Status unknownNCT04703205Phase 2